Terry Heiman-Patterson, MD, Professor of Neurology at the Lewis Katz School of Medicine at Temple University, offered insight to Reuters Health about a study published in Nature Medicine that increases in brain perivascular fibroblasts and their protein SPP1 may better predict life expectancy in patients with sporadic amyotrophic lateral sclerosis, or ALS. Dr. Heiman-Patterson was not involved in the study. MD Alert picked up the Reuters Health article.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH